Health Advance Signs Letter of Intent to Acquire Hantian Labs

LAS VEGAS, NV--(Marketwired - Sep 28, 2016) - Health Advance Inc. (OTC PINK: HADV) (Hereinafter referred to as "the Company" or "HADV") is pleased to announce it has entered into a non-binding Letter of Intent to acquire 100% interest in Hantian Labs Limited, a private UK corporation (Hereinafter referred to as "Hantian"). The acquisition is subject to due diligence by both parties, and the negotiation and execution of a definitive agreement. The agreement will be subject to certain conditions including HADV issuing 15,000,000 shares of the Company in exchange for all the issued and outstanding shares in Hantian.

The Company expects to enter into a Definitive Agreement by October 15, 2016. Once completed, HADV will also control 99% of JT Hantian LLC which represents the revenue arm of Hantian Labs. Currently, JT Hantian has sales in excess of $1,000,000 within the calendar year. "This is a very exciting time for Hantian and we are looking forward to expanding our product line in the coming months. Due to an aging global population, the desire to preserve youth, and the numerous advancements made in reversing the natural process of aging, the world market for anti-aging products is growing at a rapid rate. The need to stay young is a vortex that's attracting younger consumers and this expansion in target audience is expected to help drive the markets growth into the future," stated Managing Director, Christian Diesveld.

On closing, Hantian Labs will be held as a subsidiary of Health Advance. The Company believes the acquisition of Hantian will create additional value for Health Advance shareholders. Jordan Starkman, CEO of Health Advance, stated, "We are particularly enthused by the prospects and future growth of Hantian, and are excited to begin our advancement and expansion into the nutraceutical space."

Nutraceuticals are gaining popularity globally for their ability to prevent and fight several common diseases. In addition to this, they also aid in maintaining a youthful appearance and slowing down the aging process. The projected global value of the anti-aging market will be 274.5 Billion USD for 2016 and 291.9 Billion by 2017 according to statistics recently released.

About Hantian Labs

Hantian Labs (www.hantianlabs.com) is an emerging global leader in anti-aging and vitality nutraceutical products. Developed by a team of research scientists, athletes and beauty professionals, the Hantian line of tablets uses state-of-the-art age reversal technology to diminish the signs of aging, whilst enhancing, enriching and extending the lives of their consumers. Products, including GHBurn, Alpha Elite and Revitamar, are made at Hantian's GMP ISO 9001 and Informed Sports certified facility in the United Kingdom with the strictest quality standards. Hantian products are Medicines & Healthcare Products Regulatory Agency (MHRA) approved. Hantian also has licenses issued by the Minister of Health for Canada, issued under the authority of section 7 of the Natural Health Products Regulations, for its products GHBurn and Alpha Elite.